Cloned (Comment) | Organism |
---|---|
gene AGXT2, real-time RT-PCR enzyme expression analysis | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
mitochondrial membrane | - |
Homo sapiens | 31966 | - |
additional information | AGXT2 RT-PCR expression analysis and immunohistochemic analysis in human tissues | Homo sapiens | - |
- |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-alanine + glyoxylate | Homo sapiens | - |
pyruvate + glycine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q9BYV1 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
hepatocyte | - |
Homo sapiens | - |
kidney | convoluted tubule, strong AGXT2 expression is detected in proximal tubular epithelial cells | Homo sapiens | - |
liver | diffuse AGXT2 expression in hepatocytes, but no significant AGXT2 expression in the hepatic vasculature | Homo sapiens | - |
additional information | AGXT2 RT-PCR expression analysis and immunohistochemic analysis in human tissues, expression of key metabolic enzyme alanine:glyoxylate aminotransferase 2 in humans mainly in kidney and liver. The other tissues do not show any detectable AGXT2 mRNA | Homo sapiens | - |
renal proximal tubule epithelial cell | - |
Homo sapiens | - |
small intestine | very low content | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-alanine + glyoxylate | - |
Homo sapiens | pyruvate + glycine | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 50000, about, SDS-PAGE | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
AGT2 | - |
Homo sapiens |
AGXT2 | - |
Homo sapiens |
alanine:glyoxylate aminotransferase 2 | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
physiological function | the endogenous inhibitor of nitric oxide synthases asymmetric dimethylarginine (ADMA) can be catabolized by dimethylarginine dimethylaminohydrolase (DDAH, EC 3.5.3.18) or metabolized through an alternative pathway by alanine:glyoxylate aminotransferase 2 (AGXT2) with the formation of 2-oxo-D-(N,N-dimethylguanidino)valeric acid (ADGV). AGXT2 can metabolize the cardiovascular risk factors N-monomethylarginine (NMMA), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) | Homo sapiens |